Zimmer Holdings
(ZBH)
|
4.9 |
$123M |
|
764k |
160.82 |
Biogen Idec
(BIIB)
|
4.7 |
$118M |
|
339k |
346.27 |
Horizon Therapeutics Pub L SHS
|
4.6 |
$116M |
|
1.2M |
93.64 |
Pet Acquisition LLC -Class A
(WOOF)
|
4.4 |
$111M |
|
4.9M |
22.41 |
Regeneron Pharmaceuticals
(REGN)
|
4.3 |
$106M |
|
190k |
558.54 |
Humana
(HUM)
|
4.2 |
$106M |
|
239k |
442.72 |
CVS Caremark Corporation
(CVS)
|
4.2 |
$106M |
|
1.3M |
83.44 |
Danaher Corporation
(DHR)
|
4.1 |
$103M |
|
385k |
268.36 |
Bristol Myers Squibb
(BMY)
|
3.9 |
$99M |
|
1.5M |
66.82 |
Thermo Fisher Scientific
(TMO)
|
3.7 |
$92M |
|
183k |
504.47 |
Natera
(NTRA)
|
3.6 |
$90M |
|
790k |
113.53 |
Encompass Health Corp
(EHC)
|
3.3 |
$82M |
|
1.1M |
78.03 |
Medtronic SHS
(MDT)
|
3.0 |
$75M |
|
601k |
124.13 |
Align Technology
(ALGN)
|
2.9 |
$73M |
|
119k |
611.00 |
Stryker Corporation
(SYK)
|
2.8 |
$71M |
|
273k |
259.73 |
Nevro
(NVRO)
|
2.5 |
$62M |
|
376k |
165.79 |
Vertex Pharmaceuticals Incorporated
(VRTX)
|
2.5 |
$62M |
|
305k |
201.63 |
Maravai Lifesciences Hldgs I Com Cl A
(MRVI)
|
2.1 |
$52M |
|
1.3M |
41.73 |
Boston Scientific Corporation
(BSX)
|
2.1 |
$52M |
|
1.2M |
42.76 |
BioCryst Pharmaceuticals
(BCRX)
|
2.1 |
$51M |
|
3.2M |
15.81 |
Envista Hldgs Corp
(NVST)
|
2.0 |
$50M |
|
1.2M |
43.21 |
Universal Hlth Svcs CL B
(UHS)
|
1.9 |
$48M |
|
326k |
146.43 |
Zoetis Cl A
(ZTS)
|
1.7 |
$43M |
|
229k |
186.36 |
Veeva Sys Cl A Com
(VEEV)
|
1.7 |
$42M |
|
136k |
310.95 |
Amgen
(AMGN)
|
1.5 |
$39M |
|
158k |
243.75 |
Neurocrine Biosciences
(NBIX)
|
1.5 |
$38M |
|
390k |
97.32 |
Welltower Inc Com reit
(WELL)
|
1.4 |
$36M |
|
435k |
83.10 |
Hca Holdings
(HCA)
|
1.4 |
$35M |
|
170k |
206.74 |
McKesson Corporation
(MCK)
|
1.2 |
$31M |
|
161k |
191.24 |
AmerisourceBergen
(COR)
|
1.2 |
$30M |
|
264k |
114.49 |
Syndax Pharmaceuticals
(SNDX)
|
1.2 |
$30M |
|
1.8M |
17.17 |
Halozyme Therapeutics
(HALO)
|
1.2 |
$30M |
|
649k |
45.41 |
Ventas
(VTR)
|
1.1 |
$28M |
|
490k |
57.10 |
Tenet Healthcare Corp Com New
(THC)
|
1.0 |
$25M |
|
376k |
66.99 |
Incyte Corporation Call Option
(INCY)
|
0.9 |
$23M |
|
267k |
84.13 |
Dex
(DXCM)
|
0.9 |
$22M |
|
51k |
427.00 |
Longview Acquisition Corp Ii Com Cl A
|
0.8 |
$21M |
|
2.1M |
9.80 |
Affimed Therapeutics B V
|
0.8 |
$21M |
|
2.4M |
8.50 |
IDEXX Laboratories
(IDXX)
|
0.8 |
$19M |
|
30k |
631.54 |
Cytokinetics Com New
(CYTK)
|
0.6 |
$15M |
|
749k |
19.79 |
Deciphera Pharmaceuticals
|
0.6 |
$14M |
|
386k |
36.61 |
Research Alliance Corp Ii Com Cl A
|
0.5 |
$13M |
|
1.3M |
10.14 |
Arya Sciences Acqu Corp Iv Cl A
(ARYD)
|
0.5 |
$13M |
|
1.2M |
10.72 |
Livanova SHS
(LIVN)
|
0.4 |
$11M |
|
125k |
84.11 |
Medicus Sciences Acquisition Cl A Shs
|
0.3 |
$7.2M |
|
744k |
9.65 |
Ironwood Pharmaceuticals Com Cl A
(IRWD)
|
0.3 |
$6.7M |
|
523k |
12.87 |
Rapt Therapeutics
(RAPT)
|
0.3 |
$6.4M |
|
200k |
31.79 |
Gh Research Ordinary Shares
(GHRS)
|
0.2 |
$5.4M |
|
250k |
21.73 |
Ikena Oncology
(IKNA)
|
0.2 |
$5.3M |
|
378k |
14.04 |
Orion Acquisition Corp Com Cl A
|
0.2 |
$5.3M |
|
548k |
9.66 |
Cm Life Sciences Iii Class A Com
|
0.2 |
$5.2M |
|
500k |
10.32 |
Novavax Com New Put Option
(NVAX)
|
0.2 |
$5.0M |
|
24k |
212.30 |
Abg Acquisition Corp I Cl A Shs
|
0.1 |
$3.2M |
|
329k |
9.80 |
Galapagos Nv Spon Adr
(GLPG)
|
0.1 |
$2.8M |
|
41k |
68.89 |
Omega Alpha Spac Cl A
|
0.1 |
$2.7M |
|
271k |
9.95 |
Sarissa Capital Acquisitn Unit 10/23/2027
|
0.1 |
$2.7M |
|
262k |
10.25 |
Cyteir Therapeutics
|
0.1 |
$2.6M |
|
120k |
21.40 |
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.1 |
$2.4M |
|
234k |
10.20 |
Day One Biopharmaceuticals I
(DAWN)
|
0.1 |
$2.4M |
|
104k |
22.77 |
Monte Rosa Therapeutics
(GLUE)
|
0.1 |
$2.3M |
|
100k |
22.70 |
Merus N V
(MRUS)
|
0.1 |
$2.0M |
|
96k |
21.07 |
Jounce Therapeutics
|
0.1 |
$1.8M |
|
268k |
6.80 |
Jiya Acquisition Corp Com Cl A
|
0.1 |
$1.4M |
|
141k |
9.94 |
Atai Life Sciences Nv SHS
(ATAI)
|
0.1 |
$1.4M |
|
75k |
18.51 |
Elevation Oncology
(ELEV)
|
0.1 |
$1.4M |
|
100k |
13.57 |
Biohaven Pharmaceutical Holding
|
0.0 |
$1.1M |
|
11k |
97.09 |
Longview Acquisition Corp Ii *w Exp 99/99/999
|
0.0 |
$585k |
|
427k |
1.37 |
Mereo Biopharma Group Ads
(MREO)
|
0.0 |
$473k |
|
149k |
3.17 |
Cm Life Sciences Iii *w Exp 04/30/202
|
0.0 |
$258k |
|
100k |
2.58 |
Orion Acquisition Corp *w Exp 02/19/202
|
0.0 |
$131k |
|
137k |
0.95 |
Medicus Sciences Acquisition *w Exp 02/12/202
|
0.0 |
$83k |
|
83k |
1.00 |